| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | 10%+ Owner | Common Stock | 735,984 | 12 Feb 2024 | Indirect | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-1 Redeemable Convertible Preferred Stock | 0 | 12 Feb 2024 | Indirect | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-2 Redeemable Convertible Preferred Stock | 0 | 12 Feb 2024 | Indirect | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | 12 Feb 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 12 Feb 2024 | 6 | $0 | 4 | 10%+ Owner | 14 Feb 2024, 17:35 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | 10%+ Owner | 07 Feb 2024, 21:51 |